A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes
ClinicalTrials.gov · NCT00382239 · Registry updated: 2015-02-23
- Condition / research focus
- Type 2 Diabetes Mellitus
- Sponsor
- AstraZeneca
- Countries with listed sites
- Japan
- Registry dates and results
- Start: 2006-09. Completion: 2007-05 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- exenatide (LY2148568) (drug) — also listed as: Byetta
- exenatide (LY2148568) (drug) — also listed as: Byetta
- exenatide (LY2148568) (drug) — also listed as: Byetta
- Placebo (drug)
Where the study takes place — 14 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.